EMA will accept reference meds made outside Europe under biosimilars guidelines
The EMA plans to accept reference medicines sourced from outside the European Economic Area (EEA) under its updates biosimilar guidance.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs